Andrew YatesCSO at Artelo BiosciencesPresenter
Profile
Dr. Andy Yates has served as Artelo's Chief Scientific Officer since January 2021. Dr. Yates has more than 20 years experience in the pharmaceutical industry including 12 years as an executive at AstraZeneca. He held key roles within the medical affairs, commercial, business development and strategy functions for AstraZeneca’s in-line and development portfolio. Dr Yates has been extensively involved in the life-cycle management of key multi-billion dollar products leading to the funding and initiation of significant development programmes. Whilst in business development he led evaluations and transactions that resulted in multiple collaborative agreements with academia, biotechnology and peer pharma. Dr. Yates is a UK registered pharmacist who received his PhD in cannabinoid medicinal chemistry from the University of Nottingham.